Sung-Hoon Jung
Overview
Explore the profile of Sung-Hoon Jung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
170
Citations
1232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chng W, Wu D, Wu C, Springford A, Daly C, Jung S
Clin Lymphoma Myeloma Leuk
. 2025 Mar;
PMID: 40058983
Background: Standard-of-care treatment for patients with multiple myeloma (MM) typically includes frontline lenalidomide until disease progression, making lenalidomide-refractoriness a challenge in relapsed/refractory MM (RRMM). Lenalidomide-sparing triplet therapies, daratumumab, pomalidomide, and...
2.
Vo M, Nguyen V, Tran V, Oh H, Jung S, Bae W, et al.
Cancer Immunol Immunother
. 2025 Mar;
74(4):143.
PMID: 40056167
Despite an initial response to platinum-based chemotherapy, most patients with extensive stage of small cell lung cancer (SCLC) have a poor prognosis due to recurrence. Additionally, the benefit of immune...
3.
Jang H, Song G, Kim M, Ahn S, Ahn J, Yang D, et al.
Blood Res
. 2025 Mar;
60(1):14.
PMID: 40035999
No abstract available.
4.
Lee J, Kim S, Koh Y, Yhim H, Lee G, Min C, et al.
Cancer Res Treat
. 2025 Feb;
PMID: 39999773
Purpose: This study evaluates the Korean Cancer Study Group Geriatric Score-7 (KG-7) frailty screening tool's effectiveness in elderly multiple myeloma (MM) patients to prevent under and over-treatment. Materials And Methods:...
5.
Song G, Jang H, Kim M, Ahn S, Jung S, Ahn J, et al.
Clin Nucl Med
. 2025 Feb;
50(4):281-288.
PMID: 39957068
Purpose Of The Report: The usefulness of brain 18 F-FDG PET/CT in primary central nervous system lymphoma (PCNSL) remains underexplored. This study investigated whether early metabolic responses in interim brain...
6.
Kang K, Kim D, Lee S, Heo M, Eom H, Jung J, et al.
BMC Cancer
. 2025 Feb;
25(1):204.
PMID: 39910509
Background: In the Republic of Korea, only lenalidomide, bortezomib, ixazomib, and thalidomide monotherapy are available as maintenance therapy post-autologous stem cell transplantation (ASCT). Methods: To determine whether maintenance therapy confers...
7.
Jung S, Koh Y, Kim M, Kim J, Moon J, Min C, et al.
Blood Res
. 2025 Feb;
60(1):9.
PMID: 39903326
Multiple myeloma (MM), a hematological malignancy, is characterized by malignant plasma cell proliferation in the bone marrow. Recent treatment advances have significantly improved patient outcomes associated with MM. In this...
8.
Le T, Shitiri N, Jung S, Kwon S, Lee C
Sensors (Basel)
. 2025 Jan;
24(24.
PMID: 39771804
Nuclear medicine imaging (NMI) is essential for the diagnosis and sensing of various diseases; however, challenges persist regarding image quality and accessibility during NMI-based treatment. This paper reviews the use...
9.
Koh Y, Yoon S, Kim K, Lee J, Jung S, Yoon S, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39727014
Purpose: Daratumumab is a novel, first-in-class monoclonal antibody approved for use as monotherapy and in combination with other treatments for patients with multiple myeloma (MM). The aim of this observational...
10.
Gwak G, Kim J, Hwang U, Jung S
J Eval Clin Pract
. 2024 Oct;
PMID: 39440954
Background: Osteoarthritis (OA) is a common degenerative disease of the joints. Risk factors for OA include non-modifiable factors such as age and sex, as well as modifiable factors like physical...